Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

Methylprednisolone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for methylprednisolone acetate and what is the scope of methylprednisolone acetate patent protection?

Methylprednisolone acetate
is the generic ingredient in six branded drugs marketed by Watson Labs, Pharmacia And Upjohn, Akorn, Sandoz Inc, Teva Pharms Usa, Bel Mar, and Sandoz, and is included in seventeen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for methylprednisolone acetate. Fifteen suppliers are listed for this compound.

Summary for Generic Name: methylprednisolone acetate

Drug Master File Entries: see list39
Suppliers / Packagers: see list15
Bulk Api Vendors: see list33
Clinical Trials: see list595
Patent Applications: see list3,438
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methylprednisolone acetate at DailyMed

Pharmacology for Ingredient: methylprednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar
methylprednisolone acetate
INJECTABLE;INJECTION087135-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Teva Pharms Usa
methylprednisolone acetate
INJECTABLE;INJECTION040620-002Oct 27, 2006ABRXNoNo► Subscribe► Subscribe
Watson Labs
methylprednisolone acetate
INJECTABLE;INJECTION086507-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
methylprednisolone acetate
INJECTABLE;INJECTION011757-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Teva Pharms Usa
methylprednisolone acetate
INJECTABLE;INJECTION040557-002Feb 23, 2005ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus